ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0407

The Clinical Role of T1 Mapping Cardiac Magnetic Resonance Imaging for Detecting Cardiac Involvement in the Early Stage of Systemic Sclerosis

Munkhtuul Purevsuren1, Masae Uehara1, Masato Ishizuka1, Toru Hara1, Nobutaka Kakuda1, Taeko Tsuji1, Tadashi Yamazaki1, Miyazaki Miki2, Hayakazu Sumida2, Ayumi Yoshizaki2, Yoshihide Asano2, Shinichi Sato3, Masaru Hatano1 and Komuro Issei1, 11. Department of Cardiovascular Medicine, The University of Tokyo, Graduate School of Medicine, Tokyo, Japan., Tokyo, Japan, 22. Department of Dermatology, The University of Tokyo, Graduate School of Medicine, Tokyo, Japan., Tokyo, Japan, 3Department of Dermatology, The University of Tokyo, Graduate School of Medicine, Tokyo, Japan

Meeting: ACR Convergence 2021

Keywords: Cardiovascular, Magnetic resonance imaging (MRI), Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Systemic Sclerosis & Related Disorders – Clinical Poster I (0387–0413)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Systemic sclerosis (SSc) is characterized by skin and internal organs tissue fibrosis including the myocardium. Cardiovascular magnetic resonance (CMR) parametric mapping is a promising modality to detect diffuse myocardial fibrosis.

The study aims to detect early-stage cardiac involvement in SSc using CMR parametric mapping and evaluate the associations with clinical and laboratory findings.

Methods: 24 controls (12 female, 58.0±18.9 years) and 57 SSc patients (51 female, 59.4±12.9 years) underwent CMR at 3.0T and analyzed myocardial damage using parametric mapping and compared with clinical data.

Results: The mean disease duration in the SSc group was 3.9±7.4 years, and four patients had pulmonary hypertension. The mean left ventricular (LV) ejection fraction was 58.3±8.1 in the SSc group and 56.9±7.0 in the control group. LV global longitudinal and circumferential strain evaluated by CMR feature tracking showed no significant differences between the two groups. Focal fibrosis on late gadolinium enhancement was found in 9 SSc patients (15.7%) but none of the controls. Mid-ventricular native T1 and extracellular volume fraction were significantly higher in SSc patients compared with the control group (1331.2±65.4mesc vs. 1253.6±44.1msec, p< 0.0001 and 32.4±4.1% vs. 28.3±3.3%, p< 0.0001, respectively). There was a significant correlation between native T1 and BNP levels (r=0.353, p=0.008) in the SSc group. SSc patients were divided into two groups, low and medium native T1 group (n=37) and high native T1 group (n=19). Cutaneous vascular symptoms including digital ulcer and telangiectasia were significantly higher in the high native T1 SSc group compared with the low and medium native T1 SSc group (6 (31.5%) vs. 1 (2.7%), p=0.005 and 7 (36.8%) vs. 4 (10.8%), p=0.027). There were no differences in biventricular volume and contraction, but the left and right atrial volume index were significantly larger in the high native T1 SSc group than the low and medium native T1 SSc group (all p< 0.05). In univariate logistic regression analysis revealed that diffuse cutaneous SSc, the coexistence of digital ulcer, telangiectasia, albumin, hemoglobin, and erythrocyte sedimentation rate were independent predictors of mid-ventricular high native T1 values. In multivariate logistic regression analysis, the coexistence of digital ulcers was the only independent predictor of mid-ventricular high native T1 values in the SSc group (p=0.013 odds ratio=12, CI 1.1-138.9).

Conclusion: Native T1 mapping is a useful method to detect early myocardial damage in SSc patients. The clinician should take notice of cardiac involvement in SSc patients with progressed skin lesions even without cardiac symptoms.

Results: Myocardial native T1 and ECV values compared between controls and SSc

Results: Baseline characteristics of patients with SSc

Results: Univariate and multivariate logistic regression analysis for predicting mid-ventricular septum high native T1


Disclosures: M. Purevsuren, None; M. Uehara, None; M. Ishizuka, None; T. Hara, None; N. Kakuda, None; T. Tsuji, None; T. Yamazaki, None; M. Miki, None; H. Sumida, None; A. Yoshizaki, None; Y. Asano, None; S. Sato, None; M. Hatano, None; K. Issei, None.

To cite this abstract in AMA style:

Purevsuren M, Uehara M, Ishizuka M, Hara T, Kakuda N, Tsuji T, Yamazaki T, Miki M, Sumida H, Yoshizaki A, Asano Y, Sato S, Hatano M, Issei K. The Clinical Role of T1 Mapping Cardiac Magnetic Resonance Imaging for Detecting Cardiac Involvement in the Early Stage of Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/the-clinical-role-of-t1-mapping-cardiac-magnetic-resonance-imaging-for-detecting-cardiac-involvement-in-the-early-stage-of-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-clinical-role-of-t1-mapping-cardiac-magnetic-resonance-imaging-for-detecting-cardiac-involvement-in-the-early-stage-of-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology